With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Xconomy
SEPTEMBER 30, 2020
That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several inherited forms of the disorder. The study was small and was not designed to show statistical significance. The study was small and was not designed to show statistical significance.
Let's personalize your content